Prostate cancer screening program beneficial in top decile of polygenic risk score

Published Date: 15 Apr 2025

A prostate cancer screening program involving participants in the top decile of risk according to a polygenic risk score identifies clinically significant disease, according to a study published in the April 10 issue of the ...

Read Full News

Latest News

A Century of Schizophrenia: One Disorder or Many?

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Psychotropics Linked to Increased BMI, CVD Risk

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

Adjuvant Radiation Boosts High-Risk Bladder Cancer Control

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Blood Test Flags Mantle Cell Lymphoma Relapse Before PET-CT

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Nonpharmacologics May Reduce Anxiety, Depression in SUD

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Todays Updates

AI Saves Clinicians Time but Most Lack Training, Survey Finds

AI is saving clinicians time, but the majority of healthcare professionals say training in the technology is inadequate, ⁠inconsistent or unavailable, a global survey...

Hantavirus Outbreak Highlights the Importance of One Health

The recent hantavirus outbreak underscores how urbanization, deforestation, and rodent reservoirs can converge to shape zoonotic risk.

Alcohol Intake Tied to Increased Colorectal Cancer Risk

Dr Maurie Markman discusses a PLCO trial analysis highlighting the stark association between consistent heavy drinking and increased colorectal cancer risk.

AI Can Predict Breast Cancer Years Earlier. Too Good to Be True?

The short answer is yes. Dr F. Perry Wilson explains why he believes AI still has a role in radiology.

One Doctor’s Mission to Spread AI Literacy in Medicine

A medical oncologist seeks to use his computer science knowledge to make AI understandable to the medical community.

ASCO 2026: GI Oncology Shifts to Biomarker-Driven Care

Dr Emil Lou breaks down practice-changing GI oncology data from ASCO 2026, including transformative survival updates in pancreatic and upper GI cancers.

Interest in Alternative Menopause Treatments Surging

As menopause has become more visible online, experts see both benefits and risks, from greater patient engagement to the spread of misinformation.

Latest News

Researchers increasingly suggest that biological diversity within schizophrenia may limit efforts to identify a single defining biomarker.

Psychotropics are associated with increased BMI, and users with a high BMI genetic risk score and an unhealthy lifestyle have triple the risk for CVD, new research shows.

For patients with high-risk muscle-invasive bladder cancer, adjuvant radiotherapy improves disease control without increasing the risk of serious side effects.

Results pinpoint who has the worst prognosis and might benefit from different therapies.

Neuromodulation, mind-body therapy, and other nonpharmacologic interventions are linked to improved psychiatric symptoms in people with SUD, a meta-analysis shows.

The World Health Organization on Friday urged governments to do more to control the sale of nicotine pouches, warning ⁠that the highly addictive products were being...

News All Time

Next-Generation KRAS G12C Inhibitor Shows 'Robust' Efficacy in Advanced Lung Cancer

Responses observed in patients with and without previous exposure to other KRAS G12C inhibitors

CAR-T Trial Raises Prospect of Preventing Myeloma in High-Risk Group

All 20 smoldering myeloma patients had deep responses after one-time infusion

More Positive Survival Data in Lung Cancer With Perioperative Therapy

High rate of tumor DNA clearance with chemoimmunotherapy portends improved EFS, possibly OS

Study Linking Fruits, Veggies to Lung Cancer Raises Eyebrows

Association by way of pesticide exposure proposed, but outside experts not so sure

SCOTUS Grapples With Multibillion-Dollar Lawsuits Over Roundup Cancer Claims

Several justices seemed sympathetic to Monsanto's argument that it can't be sued under state law

Rectal Cancer 'Crisis'; Smells Like Cancer; Flushing Away Clues to Colon Cancer

News, features, and commentary about cancer-related issues

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven

However, rates were improved from previous survey results

FDA Says First 'Real-Time' Clinical Trial Is Underway

Two sponsors are on board, with a larger pilot program planned later this year

Novel Mimetic Bispecific Antibody Superior to Standard Care in Hemophilia A

Mim8 prophylaxis significantly reduced bleeding events in patients with or without inhibitors

High Rate of Surgical Success in Complex NSCLC With Neoadjuvant Chemoimmunotherapy

Three-fourths of patients had cancer-free mediastinal lymph nodes, clear surgical margins in 93%

Pooled Cord Blood Transplants Achieve Near-Perfect Results in Early Trial

Disease-free survival of 96% with no severe GVHD in acute leukemia, other blood cancers

FDA Panel Endorses Capivasertib Use in Prostate Cancer

Agency staff expressed uncertainty over whether PFS benefit was "clinically meaningful"

Paging Dr. AI; Myth Busting in Cancer; Oncologists Shine in Malpractice Survey

News, features, and commentary about cancer-related issues

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

His death followed a hospitalization for cancer treatment side effects

I Was Told I Had 6 Months to Live. That Was 20 Years Ago.

Here's what two brain surgeries taught me about public health and care access

Woman Loses 6-Year Battle With Mouth Tumor

Rare ameloblastoma rapidly recurs and metastasizes despite numerous radical excisions

Recommended News For You

A person's susceptibility to papillary thyroid cancer may be determined by variations in telomere lengthening genes.

Upping Immunotherapy Activity; A Win for Lung Screening; Looming Drug Price Break?

Researchers can now forecast how prostate cancer bone metastases will react to radium-223 treatment.

Breast density changes over time are associated with an increased risk of cancer.

For patients with clear cell renal cell carcinoma, a new PET agent allows for same-day imaging.

Novel topical fluorescent imaging technique rapidly and safely detects basal cell carcinoma

How cancer misinformation exploits the way we think

Recommended Articles For You

Unlocking the Secrets of Ringed Sideroblasts: A New Frontier in Hematology 

The Different Types of Cysts and Why They Occur: Insights from a Dermatologist  

Intrapancreatic Fat, Pancreatitis, and Cancer: Role of Cancer-Associated Fibroblasts 

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Merck enhances its oncology pipeline by means of a strategic alliance with Hengrui.

2.

A study outlines the need for policies that enhance cancer patients' autonomy and information.

3.

A study suggests that screening for liver cancer is beneficial for patients with cirrhosis.

4.

Prostate cancer screening program beneficial in top decile of polygenic risk score

5.

Atezolizumab + Cabozantinib Postpones mCRPC Progression.

1.

Mastering Surgical Oncology: Education, Certification, Trials, and Therapy Insights

2.

A New Hope: Exploring Treatment Options for Waldenstrom's Macroglobulinemia

3.

Personalized Neoantigen Vaccines and the Promise of a Less Toxic Future in Pediatric Oncology

4.

The Future of Oncology: Innovations Every Doctor Should Know

5.

Exploring The Causes and Consequences of Low Transferrin Saturation

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV

2.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part II

5.

A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part V

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot